Colorectal cancer: open trials in South Korea

70 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT04929223
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Trial Treatment · Phase 1 · Hoffmann-La Roche
National Cancer Center, Goyang-si · Chonnam National University Hwasun Hospital, Jeollanam-do · Seoul National University Bundang Hospital, Seongnam-si · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-06
NCT06983743
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1 · Erasca, Inc.
Inje University Haeundae Paik Hospital Clinical Trial Center, Haeundae · Seoul St. Mary's Hospital Clinical Trial Center, Seoul
Registry updated 2026-11-06
NCT06324357
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Trial Treatment · Phase 1/2 · Boehringer Ingelheim
CHA Bundang Medical Center, Seongnam-si · Seoul National University Bundang Hospital, Seongnam-si · Seoul National University Hospital, Seoul · Korea University Anam Hospital, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-05
NCT07549412
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Trial Treatment · Phase 3 · EMD Serono Research & Development Institute, Inc.
Kyungpook National University Chilgok Hospital, Daegu · National Cancer Center, Goyang-si · Seoul National University Bundang Hospital, Seongnam-si · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System - Division of Infectious Diseases, Seoul · The Catholic University of Korea, Seoul St. Maryâ, Seoul · Asan Medical Center, Seoul · Korea University Guro Hospital, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-11-05
NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center, Goyang-si Gyeonggi-do
Registry updated 2026-11-04
NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Trial Treatment · Phase 2 · Jazz Pharmaceuticals
Samsung Medical Center, Gangnam-Gu · Korea University Guro Hospital, Guro-gu · Chonnam National University Hwasun Hospital, Hwasun-Eup · Seoul National University Hospital, Jongno-gu · Severance Hospital, Seodaemun-gu · Asan Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Seoul National University Bundang Hospital, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon · National Cancer Center Suwon, Suwon
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Seoul National University Hospital | Oncology, Jongno -Gu · Asan Medical Center - Oncology, Seoul · Severance Hospital | Oncology, Seoul · Samsung Medical Center | Oncology, Seoul
Registry updated 2026-11-04
NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Kyungpook National University Chilgok Hospital (Site 0701), Buk-Gu · Samsung Medical Center (Site 0708), Gangnam · National Cancer Center (Site 0702), Goyang-si · Seoul National University Bundang Hospital (Site 0705), Seongnam-si · Korea University Guro Hospital (Site 0704), Seoul · Seoul National University Hospital (Site 0706), Seoul · Asan Medical Center (Site 0707), Songpa-gu · The Catholic University of Korea St. Vincent s Hospital (Site 0703), Suwon
Registry updated 2026-11-04
NCT05379595
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Trial Treatment · Phase 1/2 · Janssen Research & Development, LLC
The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul · Samsung Medical Center, Seoul
Registry updated 2026-11-03
NCT06662786
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Kyungpook National University Chilgok Hospital, Daegu · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea Seoul St Marys Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-03
NCT06663319
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Asan Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-03
NCT06750094
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Kyungpook National University Chilgok Hospital, Daegu · Korea University Anam Hospital, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul
Registry updated 2026-11-03
NCT07911267
Development and Utilization of an Integrated Clinical Genomic Database
Research · Samsung Medical Center
Samsung Medical Center, Seoul
Registry updated 2026-11-02
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Inje University Haeundae Paik Hospital, Busan · Korea University Anam Hospital, Seoul · Ajou University School of Medicine & Graduate School of Medicine, Suwon
Registry updated 2026-10-30
NCT07284849
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Trial Treatment · Phase 3 · Incyte Corporation
Samsung Changwon Hospital, Changwon-Si · National Cancer Center, Goyang-si · Seoul National University Bundang Hospital, Seongnam · CHA Bundang Medical Center, Seongnam-si · Kangbuk Samsung Hospital, Seoul · Seoul National University Hospital, Seoul · The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Korea University Anam Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Hanyang University Seoul Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul · Ajou University Hospital, Suwon
Registry updated 2026-10-30
NCT06428409
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Seoul National University Hospital (Site 0161), Seoul · Samsung Medical Center (Site 0162), Seoul · Severance Hospital, Yonsei University Health System (Site 0164), Seoul · Asan Medical Center (Site 0163), Seoul
Registry updated 2026-10-29
NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Trial Treatment · Phase 1 · Astellas Pharma Inc
Seoul · Seoul
Registry updated 2026-10-29
NCT04421820
BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
Trial Treatment · Phase 1/2 · Bold Therapeutics, Inc.
National Cancer Center, Goyang · Seoul National University Hospital, Seoul · Kangbuk Samsung Hospital, Seoul · Samsung Medical Center, Seoul · Severance Hospital Yonsei University, Seoul
Registry updated 2026-10-28
NCT07221357
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Kyungpook National University Chilgok Hospital, Deagu · National Cancer Center, Goyang-si · Seoul National University Bundang Hospital, Seongnam · Asan Medical Center, Seoul · Korea University Anam Hospital, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul
Registry updated 2026-10-23
NCT06004245
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1 · Vividion Therapeutics, Inc.
Kyungpook National University Chilgok Hospital, Daegu · National Cancer Center, Gyeonggi-do · Seoul National University Bundang Hospital, Seongnam-si · Severance hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-21
NCT07811193
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Trial Treatment · Phase 2 · Vividion Therapeutics, Inc.
Seoul National University Hospital | Oncology, Jongno -Gu · Seoul National University Bundang Hospital | Oncology, Seongnam-si, Gyeonggi-do · Samsung Medical Center | Oncology, Seoul · Severance Hospital | Oncology, Seoul · Asan Medical Center - Oncology, Seoul
Registry updated 2026-10-21
NCT07527858
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
Trial Treatment · Phase 2 · Gilead Sciences
Samsung Medical Center, Busan · Yonsei University Severance Hospital (aka Yonsei Cancer Center), Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-10-20
NCT06885034
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Seoul
Registry updated 2026-10-19
NCT07525206
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Trial Treatment · Phase 3 · AbbVie
Dong-A University Medical Center /ID# 279610, Busan · Chonnam National University Hwasun Hospital /ID# 279787, Hwasun-gun · Gachon University Gil Medical Center /ID# 279592, Incheon · CHA Bundang Medical Center /ID# 279589, Seongnam · Asan Medical Center /ID# 282732, Seoul · Seoul National University Hospital /ID# 282730, Seoul · The Catholic University Of Korea St. Vincent's Hospital /ID# 279675, Suwon
Registry updated 2026-10-19
NCT07023289
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Trial Treatment · Phase 2 · AbbVie
Seoul National University Hospital /ID# 274451, Seoul · Samsung Medical Center /ID# 274452, Seoul · Asan Medical Center /ID# 274454, Seoul
Registry updated 2026-10-09

All Colorectal cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error